ArticleBiological research2026
Lifelong cGAS deficiency leads to altered lipid storage and cholesterol homeostasis.
Article in Biological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe complex interaction between the immune system and metabolic homeostasis is becoming recognized, as immune sensors affect key metabolic tissues, including the liver and adipose tissue. The cGAS-cGAMP-STING pathway, previously recognized as a cytosolic DNA-sensing pathway, is currently associated with lipid metabolism in addition to its inflammatory function. Although STING is acknowledged for its connection to cholesterol, the metabolic functions of its upstream component molecules-the DNA sensor cGAS and the resulting product cGAMP-are largely unexplored. We propose that cGAS and cGAMP serve as crucial, previously unidentified regulators of systemic lipid homeostasis throughout the lifetime.
resultsWe investigated the long-term metabolic consequences of intrinsic cGAS deficiency, leading to the absence of cGAMP, in male mice fed on a standard chow diet. cGAS knockout (cGASKO) mice demonstrated a consistent increase in body weight across their lifespan, primarily attributed to adipocyte hypertrophy and increased adipose tissue mass. Increased weight correlated with elevated adiposity. This condition was associated with reduced weight-bearing strength, despite unchanged general locomotor activity and food intake during young age. Liver histology revealed modest cellular infiltration and absent steatosis, suggesting potential low-grade inflammation. Circulating triglyceride and glucose levels exhibited transient, age-dependent variations-decreased glucose and increased triglycerides in young age, which stabilized in adult and old ages, reflecting a possible compensatory metabolic adaptation with time. Conversely, total cholesterol levels were consistently and significantly elevated across all age groups, underscoring the importance of the cGAS-cGAMP axis in cholesterol homeostasis throughout life.
conclusionsOur study identified the cGAS-cGAMP axis as an interesting regulator of cholesterol homeostasis and fat accumulation in aging, independent of STING activation. The persistent deficiency of cGAS and cGAMP leads to lifelong hypercholesterolemia and adipose hypertrophy. This research highlights an unexpected metabolic function of the cGAS-cGAMP pathway and indicates the necessity of evaluating this axis in relation to physiological aging and metabolic disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.